Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Axel Hoos

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein Gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Journal of Clinical Oncology

English

Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

Laboratory Investigation

English

Related publications

The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Autologous Heat-Shock Protein Vaccines

Human Vaccines and Immunotherapeutics

English

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer

Frontiers in Immunology

Allergy

Immunology

2016

English

Heat Shock Protein Peptide Complex-96 Vaccination for Newly Diagnosed Glioblastoma: A Phase I, Single-Arm Trial

JCI insight

Medicine

2018

English

Endoplasmic Reticulum Heat Shock Protein Gp96/Grp94 Is a Pro-Oncogenic Chaperone, Not a Tumor Suppressor

English

Treatment of Unresectable Stage IV Metastatic Melanoma With Aviscumine After Anti-Neoplastic Treatment Failure: A Phase II, Multi-Centre Study

Journal for ImmunoTherapy of Cancer

English

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Journal of Immunology Research

English

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial

Clinical Cancer Research

Cancer Research

Oncology

2009

English

Secretory Heat Shock Protein - Gp96-Ig Chaperoned Her-2/New Vaccines

2001

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Axel Hoos

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein Gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

Related publications

The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide

Autologous Heat-Shock Protein Vaccines

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer

Heat Shock Protein Peptide Complex-96 Vaccination for Newly Diagnosed Glioblastoma: A Phase I, Single-Arm Trial

Endoplasmic Reticulum Heat Shock Protein Gp96/Grp94 Is a Pro-Oncogenic Chaperone, Not a Tumor Suppressor

Treatment of Unresectable Stage IV Metastatic Melanoma With Aviscumine After Anti-Neoplastic Treatment Failure: A Phase II, Multi-Centre Study

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial

Secretory Heat Shock Protein - Gp96-Ig Chaperoned Her-2/New Vaccines